Profile
| Metric | Value |
|---|---|
| Full Name | Abrdn Life Sciences Investors |
| Ticker | NYSE: HQL |
| Exchange | NYSE |
| Sector | Financial Services |
| Industry | Asset Management |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | teklacap.com |
| Employees | - |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $16.90 | |
| Price, 1D Change | +1.50% | |
| $488M | ||
| 10.77% | ||
| - | ||
| 0.65 | ||
| $86M | ||
| Revenue, 1Y Change | -0.35% | |
| - | ||
| EPS, 1Y Change | - |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | $0.50 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| - | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $86.39M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $16.90 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
Revenue
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $16.90 | |
| $14.29 | ||
| SMA 200 vs Price | -15.47% | |
| $17.01 | ||
| SMA 50 vs Price | +0.64% | |
| 0.65 | ||
| $0.33 | ||
| 42.91 | ||
| 14.96% | ||
| 23.79% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.50 | |
| Upcoming | N/A | N/A |
| 7.81% | ||
| Total Dividend | $1.32 | |
| $31.63M | ||
| 36.96% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $86.39M | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| $85.59M | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.95 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $513.66M | ||
| $75.54K | ||
| $515.38M | ||
| - | ||
| $1.73M | ||
| - | ||
| - | ||
| - | ||
| $720.90K |
Expenses
| Metric | Date | Value |
|---|---|---|
| - | ||
| $791.57K | ||
| - | ||
| $743.17K | ||
| - | ||
| - | ||
| - |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| $31.71M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with HQL
Data Sources & References
- HQL Official Website www.teklacap.com/hql.html
- HQL Profile on Yahoo Finance finance.yahoo.com/quote/HQL
- HQL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hql
FAQ
What is the ticker symbol for Abrdn Life Sciences Investors?
The ticker symbol for Abrdn Life Sciences Investors is NYSE:HQL
Does Abrdn Life Sciences Investors pay dividends?
Yes, Abrdn Life Sciences Investors pays dividends. The last payment was $0.50, with an ex-dividend date on November 21, 2025
What sector is Abrdn Life Sciences Investors in?
Abrdn Life Sciences Investors is in the Financial Services sector
What industry is Abrdn Life Sciences Investors in?
Abrdn Life Sciences Investors is in the Asset Management industry
What country is Abrdn Life Sciences Investors based in?
Abrdn Life Sciences Investors is headquartered in United States
When did Abrdn Life Sciences Investors go public?
Abrdn Life Sciences Investors initial public offering (IPO) was on May 1, 1992
Is Abrdn Life Sciences Investors in the S&P 500?
No, Abrdn Life Sciences Investors is not included in the S&P 500 index
Is Abrdn Life Sciences Investors in the NASDAQ 100?
No, Abrdn Life Sciences Investors is not included in the NASDAQ 100 index
Is Abrdn Life Sciences Investors in the Dow Jones?
No, Abrdn Life Sciences Investors is not included in the Dow Jones index
When does Abrdn Life Sciences Investors report earnings?
The date for Abrdn Life Sciences Investors's next earnings report has not been announced yet